volume 55 issue 5 pages 2144-2153

Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein

Publication typeJournal Article
Publication date2012-02-27
scimago Q1
wos Q1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
PubMed ID:  22332894
Drug Discovery
Molecular Medicine
Abstract
The influenza virus nucleoprotein (NP) is an emerging target for anti-influenza drug development. Nucleozin (1) and its closely related derivatives had been identified as NP inhibitors displaying anti-influenza activity. Utilizing 1 as a lead molecule, we successfully designed and synthesized a series of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents. One of the most potent compounds, 3b, inhibited the replication of various H3N2 and H1N1 influenza A virus strains with IC(50) values ranging from 0.5 to 4.6 μM. Compound 3b also strongly inhibited the replication of H5N1 (RG14), amantidine-resistant A/WSN/33 (H1N1), and oseltamivir-resistant A/WSN/1933 (H1N1, 274Y) virus strains with IC(50) values in sub-μM ranges. Further computational studies and mechanism investigation suggested that 3b might directly target influenza virus A nucleoprotein to inhibit its nuclear accumulation.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
European Journal of Medicinal Chemistry
6 publications, 4.55%
Molecules
5 publications, 3.79%
European Journal of Organic Chemistry
5 publications, 3.79%
Organic Letters
5 publications, 3.79%
Journal of Heterocyclic Chemistry
4 publications, 3.03%
Journal of Organic Chemistry
4 publications, 3.03%
Russian Journal of Organic Chemistry
3 publications, 2.27%
Acta Pharmaceutica Sinica B
3 publications, 2.27%
Journal of Molecular Structure
3 publications, 2.27%
RSC Advances
3 publications, 2.27%
Asian Journal of Chemistry
3 publications, 2.27%
Tetrahedron
2 publications, 1.52%
Archivos de Bronconeumologia
2 publications, 1.52%
Tetrahedron Letters
2 publications, 1.52%
Helvetica Chimica Acta
2 publications, 1.52%
Medicinal Research Reviews
2 publications, 1.52%
Journal of Medical Virology
2 publications, 1.52%
New Journal of Chemistry
2 publications, 1.52%
Synthetic Communications
2 publications, 1.52%
Journal of Virology
2 publications, 1.52%
Chemistry of Heterocyclic Compounds
1 publication, 0.76%
Mini-Reviews in Medicinal Chemistry
1 publication, 0.76%
Future Microbiology
1 publication, 0.76%
Royal Society Open Science
1 publication, 0.76%
Frontiers in Chemistry
1 publication, 0.76%
Natural Product Communications
1 publication, 0.76%
Antiviral Chemistry and Chemotherapy
1 publication, 0.76%
Journal of Chemical Research
1 publication, 0.76%
Monatshefte fur Chemie
1 publication, 0.76%
1
2
3
4
5
6

Publishers

5
10
15
20
25
30
35
Elsevier
31 publications, 23.48%
Wiley
25 publications, 18.94%
American Chemical Society (ACS)
12 publications, 9.09%
Springer Nature
11 publications, 8.33%
Royal Society of Chemistry (RSC)
8 publications, 6.06%
MDPI
6 publications, 4.55%
Taylor & Francis
5 publications, 3.79%
Pleiades Publishing
4 publications, 3.03%
American Society for Microbiology
4 publications, 3.03%
SAGE
3 publications, 2.27%
Asian Journal of Chemistry
3 publications, 2.27%
Bentham Science Publishers Ltd.
2 publications, 1.52%
Frontiers Media S.A.
2 publications, 1.52%
Cold Spring Harbor Laboratory
2 publications, 1.52%
Georg Thieme Verlag KG
2 publications, 1.52%
The Royal Society
1 publication, 0.76%
Public Library of Science (PLoS)
1 publication, 0.76%
Scientific Research Publishing
1 publication, 0.76%
Walter de Gruyter
1 publication, 0.76%
IntechOpen
1 publication, 0.76%
Hindawi Limited
1 publication, 0.76%
eLife Sciences Publications
1 publication, 0.76%
International Union of Crystallography (IUCr)
1 publication, 0.76%
Medknow
1 publication, 0.76%
Czech Academy of Agricultural Sciences
1 publication, 0.76%
5
10
15
20
25
30
35
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
132
Share
Cite this
GOST |
Cite this
GOST Copy
Cheng H. et al. Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 5. pp. 2144-2153.
GOST all authors (up to 50) Copy
Cheng H., Wan J., Lin M., Liu Y., Lu X., Liu J., Xu Y., Chen J., Tu Z., Cheng Y. E., DING K. Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 5. pp. 2144-2153.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/jm2013503
UR - https://doi.org/10.1021/jm2013503
TI - Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein
T2 - Journal of Medicinal Chemistry
AU - Cheng, Huimin
AU - Wan, Junting
AU - Lin, Meng-I
AU - Liu, Yingxue
AU - Lu, Xiaoyun
AU - Liu, Jinsong
AU - Xu, Yong
AU - Chen, Jianxin
AU - Tu, Zhengchao
AU - Cheng, Yih-Shyun E.
AU - DING, Ke
PY - 2012
DA - 2012/02/27
PB - American Chemical Society (ACS)
SP - 2144-2153
IS - 5
VL - 55
PMID - 22332894
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2012_Cheng,
author = {Huimin Cheng and Junting Wan and Meng-I Lin and Yingxue Liu and Xiaoyun Lu and Jinsong Liu and Yong Xu and Jianxin Chen and Zhengchao Tu and Yih-Shyun E. Cheng and Ke DING},
title = {Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein},
journal = {Journal of Medicinal Chemistry},
year = {2012},
volume = {55},
publisher = {American Chemical Society (ACS)},
month = {feb},
url = {https://doi.org/10.1021/jm2013503},
number = {5},
pages = {2144--2153},
doi = {10.1021/jm2013503}
}
MLA
Cite this
MLA Copy
Cheng, Huimin, et al. “Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein.” Journal of Medicinal Chemistry, vol. 55, no. 5, Feb. 2012, pp. 2144-2153. https://doi.org/10.1021/jm2013503.